Arialys Announces U.S. FDA Fast Track Designation for ART5803, the First Precision Therapeutic Candidate in Development for the Treatment of ANRE ...
Dysautonomia is a neurological illness that affects millions of people around the world. Yet, it isn't widely known or ...
Dysautonomia, a neurological illness, affects a large number of people globally, yet it remains relatively unknown and poorly ...
There is broad consensus on the benefits of aerobic exercise training in patients with cardiovascular disease to improve cardiorespiratory fitness and lower the risk of adverse cardiovascular events.